Related Experiment Videos
Emergency heart valve replacement: an analysis of 170 patients
Insights
Emergency heart valve surgery offers a 52% 3-year survival rate, particularly for patients with severe cardiac conditions. Prompt surgical intervention is crucial for improving outcomes in emergency valve repair.
Area of Science:
- Cardiovascular Surgery
- Cardiac Pathology
- Emergency Medicine
Background:
- Emergency heart valve procedures are critical interventions for patients with life-threatening cardiac conditions.
- Understanding outcomes across different pathological groups is essential for optimizing patient management.
Purpose of the Study:
- To analyze the outcomes of 170 emergency heart valve procedures.
- To identify patient groups with the highest mortality and attrition rates.
- To evaluate the long-term survival benefit of surgical intervention.
Main Methods:
- Retrospective analysis of 170 emergency heart valve procedures over 4.5 years.
- Classification of patients into five pathological groups: infective endocarditis, acute rheumatic carditis, previous valve operation, acute-on-chronic cardiac disease, and miscellaneous.
- Analysis of procedure types (mitral, aortic, multiple) and primary lesion (regurgitation).
Main Results:
- Highest hospital mortality observed in patients with previous valve operations (34%) and acute-on-chronic cardiac disease (31%).
- Myocardial failure was the primary cause of death.
- Overall 3-year actuarial survival rate was 52%, indicating significant salvage.
Conclusions:
- Emergency heart valve surgery provides a gratifying survival salvage for patients with a previously hopeless prognosis.
- Timely surgical intervention is crucial, as delays can negatively impact surgical cure prospects.
- Further research into optimizing management strategies for high-risk groups is warranted.
Abstract:
The results of 170 emergency heart valve procedures performed during a 4 1/2-year period were analyzed. Five pathological groups of patients were recognized: those with infective endocarditis (Group 1, 28 patients); acute rheumatic carditis (Group 2, 43 patients); previous valve operation (Group 3, 29 patients); acute-on-chronic cardiac disease (Group 4, 67 patients); and miscellaneous conditions (Group 5, 3 patients). Mitral, aortic, and multiple valve procedures were performed on 58, 65, and 44 patients, respectively. The most common functional lesion was regurgitation. Hospital mortality was highest in Groups 3 (34%) and 4 (31%). By contrast, among the hospital survivors, the highest rate of attrition was in Group 2. Myocardial failure was the predominat cause of death. In view of the hopeless prognosis without operation, the 52% overall 3-year actuarial survival is a gratifying salvage. Unnecessary procrastination can only jeopardize the prospects for surgical cure.